Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - a predictor of tumour stage
1997

TIMP-2 as a Predictor of Tumor Stage in Colorectal Cancer

Sample size: 212 publication Evidence: moderate

Author Information

Author(s): P Ring, K Johansson, M Hoyhtya, K Rubin, G Lindmark

Primary Institution: Uppsala Biomedical Centre, University of Uppsala

Hypothesis

Can TIMP-2 and MMP expressions predict tumor stage and survival time in colorectal cancer?

Conclusion

TIMP-2 expression is valuable for distinguishing between localized and metastatic colorectal cancer but does not predict micrometastases in potentially curable patients.

Supporting Evidence

  • Positive expression of TIMP-2 was found significantly more often in localized tumors than in tumors with metastases.
  • Patterns of TIMP-2 expression correlated with longer survival time.
  • A large number of MMP-9-positive macrophages correlated with poor tumor differentiation.

Takeaway

This study looked at a protein called TIMP-2 in cancer samples to see if it could help doctors tell how serious the cancer is. They found that TIMP-2 can show if the cancer is localized or spread, but it can't tell if someone will have tiny cancer spots that are hard to see.

Methodology

Immunohistochemical staining of frozen tumor sections from 212 patients was performed to assess TIMP-2 and MMP expressions.

Limitations

TIMP-2 expression could not predict which potentially cured patients would have micrometastases.

Participant Demographics

212 patients (122 women, 90 men) aged 40 to 92 years, median age 70 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication